HCA Healthcare, Inc. (HCA)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for HCA is $468.39, 2.1% above the last close of $458.84 on Oct 16, 2026; targets range from $367.57 to $576.33. Rating consensus: Hold.
Snapshot
- P/E15.4x
- P/E vs sector-45.4%
- P/E vs own-1.3%
- Target upside+2.1%
- ConsensusHold
- Market cap$99.34B
- FCF yield+6.0%
- InsidersNone in 90d
- Earnings in11d
- News0.00
Why it moved
HCA Healthcare, Inc. (HCA) fell 2.1% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to HCA.
0 stories on the day (30-day average 0.8).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $458.84 · +10.1% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI63
- Support-5.1%
- Resistance+1.2%
- Off 52w high-15.4%
- Off ATH-15.4%
- 52w range$458.84
- Bollingerupper half
- MACD2.59
- ATR+2.7%
- Volume1.5x
Analyst price targets
18 firms with a target in the last 12 months · last close $458.84 · as of Oct 16, 2026
Strong buy 1 · Buy 14 · Hold 10 · Sell 1 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +8.7% year over year, free cash flow 5.5% of revenue, operating margin 15.2%.
| Q2 FY2026 | Jun 30, 2026 | $20.23B | 7.62 | $1.1B | 15.2% | 15.2% | 8.4% |
| Q1 FY2026 | Mar 31, 2026 | $19.11B | 7.15 | $895M | 15.0% | 15.0% | 8.5% |
| Q4 FY2025 | Dec 31, 2025 | $19.51B | 8.14 | $870M | 41.9% | 16.3% | 9.6% |
| Q3 FY2025 | Sep 30, 2025 | $19.16B | 6.96 | $3.13B | 41.8% | 15.5% | 8.6% |
| Q2 FY2025 | Jun 30, 2025 | $18.61B | 6.83 | $3.03B | 41.0% | 15.9% | 8.9% |
| Q1 FY2025 | Mar 31, 2025 | $18.32B | 6.45 | $660M | 41.3% | 15.6% | 8.8% |
| Q4 FY2024 | Dec 31, 2024 | $18.29B | 5.63 | $1.27B | 41.4% | 15.6% | 7.9% |
| Q3 FY2024 | Sep 30, 2024 | $17.49B | 4.89 | $2.32B | 39.9% | 13.8% | 7.3% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 2 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 3 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 4 | | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 5 |  | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 6 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 7 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 8 |  | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.